Hapbee is powered by patented ultra-low radio frequency energy (ulRFE®) technology invented by EMulate Therapeutics, Inc., a technology company based in Seattle, WA. The ulRFE® technology, in which EMulate has invested approximately US$70 million to develop over the past 15 years, is backed by 32 patents that relate to Hapbee. Hapbee has exclusive global licenses for the non-medical use of ulRFE® technology. You can learn more about therapeutic applications of ulRFE® technology at https://emulatetx.com/our-science/scientific-platform
Quantitative easing (QE) occurs when central banks, such as the U.S. Federal Reserve, create new money to buy government bonds or other...
MyCardia's My-Cam Offers At-Home Heart Rate Monitoring. LIVE QUOTE